Brassica Protection Products LLC Safety Statement
Posted on: Tuesday, 28 April 2009, 08:42 CDT
It is important for consumers, the media, and all of those involved in the growing, producing and selling of BroccoSprouts(R) broccoli sprouts, licensed by Brassica Protection Products LLC, to know that BroccoSprouts are not implicated in this general advisory and are safe to consume. The FDA warning explicitly states that "other types of sprouts have not been implicated at this time."
Brassica strictly requires that its growers follow all FDA guidance precisely to ensure the highest level of food safety practices in growing BroccoSprouts. The sprouts are grown under Good Manufacturing Practices (GMP) and the Hazardous Analysis Critical Point Program (HACCP). BroccoSprouts seeds are sanitized before entering the growing process. Then every batch of sprouts is tested for E. coli 0157 and Salmonella before being shipped to the marketplace. If any possible contamination is found, the sprouts are destroyed. Brassica requires all of its growers to conduct regular food safety audits to ensure compliance with HACCP and GMP; Brassica itself conducts an additional independent audit to ensure strict compliance with the FDA guidance.
The FDA site "reminds retailers that it is prudent to sell sprouts from growers who follow FDA's recommendations."
Anyone with questions or concerns is encouraged to call
Link to FDA Guidance: http://vm.cfsan.fda.gov/~acrobat/fr991027.pdf
SOURCE BroccoSprouts/Brassica
Source: PR Newswire
Related Articles
- FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say
- Reportable Food Registry Draft Guidance Published for Comment by FDA
- KVH Industries Builds 25,000th Fiber Optic Gyro, Meeting Growing Demand for Guidance and Stabilization Products
- Dueling Produce Safety Standards Highlight Void Left by Lack of FDA Regulation
- FDA Funding Will Increase in Tough Budget Year
- Wyeth Provides Update on Timing of FDA Inspection of Guayama Facility, Reaffirms 2007 Guidance and Comments on Hormone Therapy Litigation
- A Century of Ensuring Safe Foods and Cosmetics
- CVBT Announces It Will Begin U.S. FDA-Authorized Clinical Trials in Diabetic Patients With Open Wounds
- FDA Approves Isotretinoin Pregnancy Risk Management Program
- FDA Wants Easier-To-Read Warnings on Drug Ads
 |
 |
User Comments (0)
RSS Feeds